Molecules (May 2024)

Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs

  • Changlin Xu,
  • Nida Amna,
  • Yuchen Shi,
  • Rong Sun,
  • Chenhui Weng,
  • Jiaoyu Chen,
  • Huaxing Dai,
  • Chao Wang

DOI
https://doi.org/10.3390/molecules29112436
Journal volume & issue
Vol. 29, no. 11
p. 2436

Abstract

Read online

Myeloid-derived suppressor cells (MDSCs) are recognized as major immune suppressor cells in the tumor microenvironment that may inhibit immune checkpoint blockade (ICB) therapy. Here, we developed a Stattic-loaded mesoporous silica nanoparticle (PEG-MSN-Stattic) delivery system to tumor sites to reduce the number of MDSCs in tumors. This approach is able to significantly deplete intratumoral MSDCs and thereby increase the infiltration of T lymphocytes in tumors to enhance ICB therapy. Our approach may provide a drug delivery strategy for regulating the tumor microenvironment and enhancing cancer immunotherapy efficacy.

Keywords